Kaiser Health News addressed the rising price of naloxone, the opioid overdose reversal drug. Kaleo, a privately-held pharmaceutical company, makes an injector called Evzio containing naloxone, a relatively old and inexpensive medication. More than 33,000 people are believed to have died from opioid overdoses in 2015. As demand for Kaleo’s product has grown, the company has raised its twin-pack price to $4,500, from $690 in 2014.
Further coverage here.